comparemela.com

Latest Breaking News On - Editorial panel meeting - Page 1 : comparemela.com

Profound Medical Corp (NASDAQ:PROF) Q1 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Profound Medical First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

United statesStephen kilmerRaymond jamesBrian gagnonRahul sarugaserArun menawatBen haynorRashed dewanMichael sarconeJoshua jenningsSociety of interventional radiologyChina national medical products administrationMedicaid servicesGrade groupEditorial panel onMeeting scientific program

Profound Medical is heading higher, says Raymond James

Raymond James analyst Rahul Sarugaser provided an update to clients on Wednesday where he maintained a “Strong Buy” rating on Profound Medical.

United statesRahul sarugaserArun menawatRaymond jamesEditorial panel meetingAmerican urological association meetingProfound medicalProfound medical stock quoteUrological associationHigh intensity focused ultrasoundPanel meeting

BlueWind Medical Announces Key Milestone as AMA Issues Unique Category III CPT Code for Subfascial Placement of Tibial Neurostimulators

/PRNewswire/ BlueWind Medical, Ltd., an innovative medical device company that aims to transform neuromodulation therapy for OAB by providing physicians and.

United statesDan lemaitreEditorial panel meetingBluewind medical ltdAmerican urological associationNational association for continencePrnewswire bluewind medical ltdCenters for medicareEditorial panelAmerican medical associationUs public healthSummary of panel actionsMedicaid servicesBluewind systemWind medicalCurrent procedural terminology

Profound Medical Announces Third Quarter 2022 Financial

TORONTO, Nov. 03, 2022 (GLOBE NEWSWIRE) Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device.

United statesStephen kilmerAbbey goodmanLaurence klotzInternational financial reporting standardsEditorial panel meetingDrug administrationUniversity of torontoChina national medical products administrationProstate cancer researchHealth canadaInternational accounting standards boardInternational accounting standardsRecent corporateCurrent procedural terminologyTransurethral ultrasound ablation

Profound Medical Provides TULSA-PRO® Reimbursement Update

TORONTO, Sept. 02, 2022 (GLOBE NEWSWIRE) Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical.

United statesStephen kilmerArun menawatEditorial panel meetingDrug administrationUs centers for medicareChina national medical products administrationHealth canadaMedicaid servicesTransurethral ultrasound ablationCurrent procedural terminologyEditorial panelHospital outpatient prospective payment systemHumanitarian device exemptionToronto stock exchange prnRofound medical inc

vimarsana © 2020. All Rights Reserved.